Risk analysis for the definition of representative drug for the formation of the quality review at the pharmaceutical enterprise
A method for efficient use of resources in formation of the quality review of product in the pharmaceutical company based on a selection of the representative drug is developed. By the risk analysis methods HACCP "Hazard Analysis and Critical Control Points" and FMEA "Procedures for failure mode and effects analysis" identified potential hazards and the proposed ranking algorithm to select a representative drug. The procedure will reduce the amount of resources involved in the formation of the quality review without compromising the objectivity of its results.
2. Popov A.Yu., Meshkovsky A.P. Risk Analysis System (HACCP) as the first step in the transition to work according to the rules of proper industrial practice (GMP) // Pharmamatka. - 2002. - No. 4. - P. 62-64.
This work is licensed under a Creative Commons Attribution 4.0 International License.